Cancer Research Cancer Research Funding Available  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 5599-5601, November 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, R. E.
Right arrow Articles by Vose, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, R. E.
Right arrow Articles by Vose, D. L.

Determination of Continuous Atracurium Infusion Rate in Dogs Undergoing Whole-Body Hyperthermia1

Robert E. Meyer2, Rodney L. Page, Donald E. Thrall, Mark W. Dewhirst and Donyelle L. Vose

School of Veterinary Medicine, North Carolina State University [R. E. M., R. L. P., D. E. T., D. L. V.], Raleigh 27606 and Division of Radiation Oncology, Duke University Medical Center [M. W. D.], Durham, North Carolina 27710

Infusion rates for atracurium were calculated from multiple bolus injection data for normothermic (38°C; n = 4) and hyperthermic (42°C; n = 14) dogs anesthetized with thiopental and oxymorphone while undergoing whole-body hyperthermia treatment. The calculated infusion rate for atracurium at 38°C was 6.2 ± 0.3 µg/kg/min and the calculated infusion rate at 42°C was 8.5 ± 0.4 µg/kg/min. Infusion of atracurium at the calculated infusion rate of 8.5 µg/kg/min produced an estimated 90–100% neuromuscular blockade during heating from 38–42°C and at 42°C. Following discontinuation of the infusion and cooling to 38°C, neuromuscular function returned to normal within 20 min with no evidence of recurarization. Atracurium infusion rates appear to be linear and related to body temperature from 26–42°C. Clinically useful neuromuscular blockade in dogs may be obtained during whole-body hyperthermia by utilizing the 42°C atracurium infusion rate throughout the 38–42°C heating phase.

1 Resources used to support this research were partially provided by the State of North Carolina.

2 To whom requests for reprints should be addressed, at Department of Anatomy, North Carolina State University, School of Veterinary Medicine, 4700 Hillsborough Street, Raleigh, NC 27606.

Received 4/11/86. Revised 8/ 5/86. Accepted 8/ 8/86.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.